Cargando…

Chloroquine: Prolonged corrected QT interval following off label use: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119609/ http://dx.doi.org/10.1007/s40278-021-95787-1

Ejemplares similares

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Multiple drugs: Increased corrected QT interval and off label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Chloroquine/dalteparin sodium/hydroxycarbamide: Prolongation of the QTc interval secondary to off-label use and lack of efficacy: case report
Publicado: (2021)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports
Publicado: (2021)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Chloroquine: Cardiac toxicity following off label use: case report
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Chloroquine: Off-label use, haemolysis and methaemoglobinaemia: case report
Publicado: (2020)

Chloroquine/tocilizumab: Leucopenia and liver injury following off-label use: case report
Publicado: (2020)

Azithromycin/chloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Chloroquine/hydroxychloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Chloroquine: High troponin I level following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_do48peb3uvusojvifnv0i9q4if